digital currency benefits Top

Kremlin: (Asked about Russian Foreign Minister Lavrov's diplomatic means to provide Assad with safe passage) There is nothing to add to this.Senior energy safety official: Poland will start looking for partners for the construction of the second nuclear power plant in early 2025.Today, a total of 95 A-shares traded in bulk, with Beijing-Shanghai High-speed Railway, Salt Lake Shares and Jin Chengxin among the top. Today (December 11th), a total of 95 A-shares traded in bulk, with a total turnover of 6.031 billion yuan, among which Beijing-Shanghai High-speed Railway, Salt Lake Shares and Jin Chengxin ranked first, with turnover of 3.797 billion yuan, 478 million yuan and 259 million yuan respectively. In terms of transaction price, 14 stocks were traded at parity, 4 at premium and 77 at discount; Yingtai Bio, Songyuan Resources and Beijing-Shanghai High-speed Railway are among the top premium rates, with premium rates of 9.13%, 2.19% and 1.61% respectively. Gobijia, Junpu Intelligent and Guoke are among the top discount rates, with discount rates of 28.86%, 25.79% and 22.46% respectively.

Guanghua Technology: Breaking the dependence on the import of key raw materials for daily chemicals and meeting the high-end diversified needs. In the global oral care industry, tin salt is a key raw material, which is widely used in toothpaste and professional oral care products because of its excellent effects of preventing dental caries, anti-sensitivity, reducing gingival bleeding and fighting gingivitis. However, the domestic market has long relied on imports for this key raw material, and the production cost remains high, which seriously restricts the competitiveness of our oral care products in the international market. Guanghua Technology has made a breakthrough in this field, successfully breaking the long-term dependence on imports, taking the lead in becoming a domestic enterprise to realize large-scale production of this special effect ingredient, significantly reducing the cost of key raw materials for customers, and further enhancing the competitiveness of China manufacturing in the international market.Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was investigated. Luo Xingfa, former party secretary and president of Guangyuan Radio and TV University and former president of Guangyuan Cadre Network College, was suspected of serious violation of the law and is currently under disciplinary review and supervision investigation by the Supervision Committee of Guangyuan Municipal Commission for Discipline Inspection.Wanfang Development: A supplementary agreement on equity transfer of RMB 12.3 million was signed, and Wanfang Development announced that the company held the 66th meeting of the 9th Board of Directors on December 11th, 2024, at which the Proposal on the Progress of Selling a wholly-owned subsidiary and Signing a Supplementary Agreement was reviewed and approved. The Company signed Supplementary Agreement III to the Equity Transfer Agreement with Beijing Tianyuan and Beijing Baiyu, and Beijing Baiyu will pay the remaining equity transfer amount of RMB 12.3 million to the Company before December 31, 2025. As of the disclosure date of the announcement, Beijing Baiyu has paid 77.7 million yuan of equity transfer to the company, and the remaining 12.3 million yuan of equity transfer has not been paid. The company has transferred its 86.3333% equity of Beijing Tianyuan to Beijing Baiyu, so far, the company holds 13.6667% equity of Beijing Tianyuan.

The Ministry of Finance successfully issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong. On December 11th, the Ministry of Finance of People's Republic of China (PRC) issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong Special Administrative Region for institutional investors, which was widely welcomed by investors, with a subscription multiple of 3.58 times. Among them, the two-year (additional issuance) is 2 billion yuan, and the issue price is 100.62 yuan, corresponding to the issue interest rate of 1.70%; 3-year (additional issuance) 2 billion yuan, the issue price is 101.28 yuan, corresponding to the issue interest rate of 1.70%; 5-year (additional issuance) 2 billion yuan, the issue price is 102.41 yuan, corresponding to the issue interest rate of 1.80%.Analysts commented on the US CPI in November: the data is in line with expectations, and there may be four interest rate cuts next year. Brian Jacobsen, chief economist of Annex Wealth Management, said: "There is nothing unexpected in the CPI report, and everything is in line with expectations. Housing cost is still the main driver of inflation. With the employment report and inflation report, nothing can stop the Fed from cutting interest rates by 25 basis points next week. What will be exciting is the summary of the Fed's economic forecast. There may be four interest rate cuts in 2025, and inflation will eventually fall to the target level. "The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)